Literature DB >> 10978293

Estimate of the mutation rate per nucleotide in humans.

M W Nachman1, S L Crowell.   

Abstract

Many previous estimates of the mutation rate in humans have relied on screens of visible mutants. We investigated the rate and pattern of mutations at the nucleotide level by comparing pseudogenes in humans and chimpanzees to (i) provide an estimate of the average mutation rate per nucleotide, (ii) assess heterogeneity of mutation rate at different sites and for different types of mutations, (iii) test the hypothesis that the X chromosome has a lower mutation rate than autosomes, and (iv) estimate the deleterious mutation rate. Eighteen processed pseudogenes were sequenced, including 12 on autosomes and 6 on the X chromosome. The average mutation rate was estimated to be approximately 2.5 x 10(-8) mutations per nucleotide site or 175 mutations per diploid genome per generation. Rates of mutation for both transitions and transversions at CpG dinucleotides are one order of magnitude higher than mutation rates at other sites. Single nucleotide substitutions are 10 times more frequent than length mutations. Comparison of rates of evolution for X-linked and autosomal pseudogenes suggests that the male mutation rate is 4 times the female mutation rate, but provides no evidence for a reduction in mutation rate that is specific to the X chromosome. Using conservative calculations of the proportion of the genome subject to purifying selection, we estimate that the genomic deleterious mutation rate (U) is at least 3. This high rate is difficult to reconcile with multiplicative fitness effects of individual mutations and suggests that synergistic epistasis among harmful mutations may be common.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10978293      PMCID: PMC1461236     

Source DB:  PubMed          Journal:  Genetics        ISSN: 0016-6731            Impact factor:   4.562


  35 in total

1.  A high-stakes gamble on genome sequencing.

Authors:  E Marshall
Journal:  Science       Date:  1999-06-18       Impact factor: 47.728

2.  Toward a phylogenetic classification of Primates based on DNA evidence complemented by fossil evidence.

Authors:  M Goodman; C A Porter; J Czelusniak; S L Page; H Schneider; J Shoshani; G Gunnell; C P Groves
Journal:  Mol Phylogenet Evol       Date:  1998-06       Impact factor: 4.286

3.  Mutation rates differ among regions of the mammalian genome.

Authors:  K H Wolfe; P M Sharp; W H Li
Journal:  Nature       Date:  1989-01-19       Impact factor: 49.962

4.  Synonymous and nonsynonymous substitutions in mammalian genes and the nearly neutral theory.

Authors:  T Ohta
Journal:  J Mol Evol       Date:  1995-01       Impact factor: 2.395

5.  A molecular approach to estimating the human deleterious mutation rate.

Authors:  A S Kondrashov; J F Crow
Journal:  Hum Mutat       Date:  1993       Impact factor: 4.878

6.  An evaluation of the molecular clock hypothesis using mammalian DNA sequences.

Authors:  W H Li; M Tanimura; P M Sharp
Journal:  J Mol Evol       Date:  1987       Impact factor: 2.395

7.  Sex differences in mutation rate in higher primates estimated from AMG intron sequences.

Authors:  W Huang; B H Chang; X Gu; D Hewett-Emmett; W Li
Journal:  J Mol Evol       Date:  1997-04       Impact factor: 2.395

Review 8.  Sex biases in the mutation rate.

Authors:  L D Hurst; H Ellegren
Journal:  Trends Genet       Date:  1998-11       Impact factor: 11.639

9.  Estimate of the genomic mutation rate deleterious to overall fitness in E. coli.

Authors:  T T Kibota; M Lynch
Journal:  Nature       Date:  1996-06-20       Impact factor: 49.962

10.  Male-driven evolution of DNA sequences.

Authors:  L C Shimmin; B H Chang; W H Li
Journal:  Nature       Date:  1993-04-22       Impact factor: 49.962

View more
  435 in total

1.  Are rare variants responsible for susceptibility to complex diseases?

Authors:  J K Pritchard
Journal:  Am J Hum Genet       Date:  2001-06-12       Impact factor: 11.025

2.  SNPSTRs: empirically derived, rapidly typed, autosomal haplotypes for inference of population history and mutational processes.

Authors:  Joanna L Mountain; Alec Knight; Matthew Jobin; Christopher Gignoux; Adam Miller; Alice A Lin; Peter A Underhill
Journal:  Genome Res       Date:  2002-11       Impact factor: 9.043

Review 3.  An evolutionary perspective on protein moonlighting.

Authors:  Shelley D Copley
Journal:  Biochem Soc Trans       Date:  2014-12       Impact factor: 5.407

4.  Effect of misoriented sites on neutrality tests with outgroup.

Authors:  Emmanuelle Baudry; Frantz Depaulis
Journal:  Genetics       Date:  2003-11       Impact factor: 4.562

5.  DNA enrichment by allele-specific hybridization (DEASH): a novel method for haplotyping and for detecting low-frequency base substitutional variants and recombinant DNA molecules.

Authors:  Alec J Jeffreys; Celia A May
Journal:  Genome Res       Date:  2003-10       Impact factor: 9.043

6.  Inferences about human demography based on multilocus analyses of noncoding sequences.

Authors:  Anna Pluzhnikov; Anna Di Rienzo; Richard R Hudson
Journal:  Genetics       Date:  2002-07       Impact factor: 4.562

7.  Male-biased transmission of deleterious mutations to the progeny in Arabidopsis thaliana.

Authors:  Carrie-Ann Whittle; Mark O Johnston
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-24       Impact factor: 11.205

8.  A history of recurrent positive selection at the toll-like receptor 5 in primates.

Authors:  Gabriela Wlasiuk; Soofia Khan; William M Switzer; Michael W Nachman
Journal:  Mol Biol Evol       Date:  2009-01-29       Impact factor: 16.240

9.  A new approach to estimate parameters of speciation models with application to apes.

Authors:  Celine Becquet; Molly Przeworski
Journal:  Genome Res       Date:  2007-08-21       Impact factor: 9.043

10.  Functional constraints and frequency of deleterious mutations in noncoding DNA of rodents.

Authors:  Peter D Keightley; Daniel J Gaffney
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-03       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.